ArticleBiophotonics discovery2026
Evaluation of a polarization-sensitive, dual-wavelength wearable photoplethysmography sensor across a range of skin tones.
Article in Biophotonics discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: High-quality photoplethysmography (PPG) signals are essential for accurate extraction of cardiovascular metrics such as heart rate, heart rate variability, and perfusion index (PI). However, signal degradation for individuals with dark skin tones can compromise PPG quality and pose challenges for equitable sensing. Aim: We developed a dual-wavelength, polarization-sensitive PPG device to assess PI across a range of skin tones. Approach: To evaluate the impact of polarization on PPG signal quality, we recorded PI for co-polarized (polarized illumination and parallel-aligned polarized detection) and cross-polarized conditions (polarized illumination and orthogonally aligned polarized detection) at 655 and 940 nm in participants representing light, medium, and brown skin tone categories. Skin tone classification was based on the individual typology angle values derived from the CIE L*b* color space measurements. Results: At 940 nm, light from the cross-polarized light channel significantly increases PI ( Conclusions: Our results suggest that the cross-polarized condition improves PPG signal quality by reducing the influence of superficial scattering and enhancing deeper vascular signals. This approach may be especially beneficial for individuals with darker skin tones and offers a promising path toward more robust and inclusive physiological monitoring using PPG-based technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.